Karyopharm Therapeutics Inc (KPTI): Next-Year EPS Estimate 28.22%
As of 2026-05-14, Karyopharm Therapeutics Inc (KPTI) has a next-year EPS growth estimate of 28.22%.
On 2026-05-14, analyst consensus for KPTI's next-year EPS growth shifted from 29.22% to 28.22% — a negative change of 1.00 percentage points. Current-year growth is projected at 75.77%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.22%
- EPS growth this year
- 75.77%
- EPS next quarter (est)
- -$1.24
- Last price
- $9.06
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-14 | 28.22% | 75.77% | -$1.24 | $9.06 |
| 2026-05-13 | 29.22% | 75.95% | -$1.42 | $8.90 |
| 2026-05-12 | 29.22% | 75.95% | -$1.42 | $8.91 |
| 2026-05-11 | 29.22% | 75.95% | -$1.42 | $8.81 |
| 2026-05-10 | 29.22% | 75.95% | -$1.42 | $8.64 |
| 2026-05-07 | 29.22% | 75.95% | -$1.42 | $8.85 |
| 2026-05-06 | 29.22% | 75.95% | -$1.42 | $9.02 |
| 2026-05-05 | 29.22% | 75.95% | -$1.42 | $9.41 |
| 2026-05-04 | 29.22% | 75.95% | -$1.42 | $9.30 |
| 2026-05-03 | 29.22% | 75.95% | -$1.42 | $8.77 |
| 2026-04-30 | 29.22% | 75.95% | -$1.42 | $8.31 |
| 2026-04-29 | 29.22% | 75.95% | -$1.42 | $8.40 |
| 2026-04-28 | 27.15% | 75.63% | -$1.42 | $8.60 |
| 2026-04-27 | 27.15% | 75.63% | -$1.42 | $8.66 |
| 2026-04-26 | 27.15% | 75.63% | -$1.42 | $8.66 |
| 2026-04-24 | 27.15% | 75.63% | -$1.42 | $8.66 |
| 2026-04-23 | 27.15% | 75.63% | -$1.42 | $8.75 |
| 2026-04-22 | 27.15% | 75.63% | -$1.42 | $9.55 |
| 2026-04-21 | 27.15% | 75.63% | -$1.42 | $9.17 |
| 2026-04-20 | 27.15% | 75.63% | -$1.42 | $8.94 |
| 2026-04-19 | 27.15% | 75.63% | -$1.42 | $8.61 |
| 2026-04-16 | 27.15% | 75.63% | -$1.42 | $8.66 |
| 2026-04-15 | 27.15% | 75.63% | -$1.42 | $8.56 |
| 2026-04-14 | 27.15% | 75.63% | -$1.42 | $8.45 |
| 2026-04-13 | 27.15% | 75.63% | -$1.42 | $8.28 |
| 2026-04-12 | 27.15% | 75.63% | -$1.42 | $8.00 |
| 2026-04-10 | 27.15% | 75.63% | -$1.42 | $7.97 |
| 2026-04-09 | 27.15% | 75.63% | -$1.42 | $8.16 |
| 2026-04-08 | 27.15% | N/A | -$1.42 | $7.25 |
| 2026-04-07 | 27.15% | N/A | -$1.42 | $7.21 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Karyopharm Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-14, Karyopharm Therapeutics Inc (KPTI) has a next-year EPS growth estimate of 28.22%, based on analyst consensus.
When was the latest EPS estimate revision for KPTI?▾
The most recent revision occurred on 2026-05-14, when analysts adjusted the next-year EPS growth estimate from 29.22% to 28.22%.
What sector and industry does Karyopharm Therapeutics Inc belong to?▾
Karyopharm Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KPTI appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Karyopharm Therapeutics Inc (KPTI) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports